RNA, 7SL, cytoplasmic 228, pseudogene (RN7SL228P)

RN7SL228P, officially "RNA, 7SL, cytoplasmic 228, pseudogene," is a non-coding genomic locus classified as a **pseudogene** and part of the large family of 7SL RNA-derived sequences in the human genome[1][5][3]. Canonical 7SL RNA is the functional RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting nascent proteins to the endoplasmic reticulum membrane[6][7]. In contrast, pseudogenes like RN7SL228P **do not produce active proteins or functional RNAs, but result from reverse transcription events and insertion into the genome**[3][5]. While some pseudogenes can act as regulatory non-coding RNAs influencing their parent gene (by mechanisms such as antisense RNA, microRNA sponging, or competitive binding to RNA-binding proteins), there is currently no evidence linking RN7SL228P to such a role[1][4]. Its annotation is for genomic reference, not for functional or clinical relevance. **Key notes:** - The presence of "pseudogene" in the name indicates that this locus is *not* a functional gene or therapeutic receptor/enzyme but a genomic relic[1][5][3]. - The gene product does **not participate in canonical biological processes or disease mechanisms**, nor is it recognized as a druggable target. - Current literature does not support any use or relevance as a biomarker, nor any safety concern related to RN7SL228P. **Structured information:** - Use the full canonical name "RNA, 7SL, cytoplasmic 228, pseudogene" for this locus. - It should not be listed as a therapeutic target or considered actively in drug discovery endeavors.

Other names

RN7SL228PRNA, 7SL, cytoplasmic 228, pseudogene

None; Not a canonical druggable molecule.